hUC-MSCs: Clinical Trials

4 trials of hUC-MSCs, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 recruiting. 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Unknown 3, Recruiting 1
Phase 23Unknown 2, Recruiting 1

Follow hUC-MSCs: new trials by email Literature Review of hUC-MSCs trials Research Report on hUC-MSCs

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase Ⅰ/Ⅱa Trial Evaluating Intravenous hUC-MSCs Injection for Safety, Tolerability and Efficacy in Patients With POI
hUC-MSCs Injection (Phase I), hUC-MSCs Injection (Phase IIa), Placebo - Premature Ovarian Insufficiency
Phase 1 / Phase 2RecruitingShenzhen Wingor Biotechnology Co., Ltd.592026-08-032026-08-20
HUC-MSC for Treatment of High-risk HPV Infection
hUC-MSCs, Saline+albumin - Human Papillomavirus Viruses, Mesenchymal Stem Cells
Phase 1 / Phase 2UnknownShanghai East Hospital602024-03-012024-09-24
Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy
HUC-MSCs, Lipoic Acid - Diabetic Peripheral Neuropathy Type 2
Phase 1 / Phase 2UnknownWuhan Central Hospital422022-05-192022-08-19
Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes
HUC-MSCs, Injectable Collagen Scaffold + HUC-MSCs - Erectile Dysfunction, Type 1 Diabetes Mellitus
Phase 1UnknownChinese Academy of Sciences302015-09-012019-01-25

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Diabetes Mellitus, Type 1 (1)  ·  Erectile Dysfunction (1)  ·  Primary Ovarian Insufficiency (1)

Sponsors

Chinese Academy of Sciences (1)  ·  Shanghai East Hospital (1)  ·  Shenzhen Wingor Biotechnology Co., Ltd. (1)  ·  Wuhan Central Hospital (1)

Countries

China (4)

Top investigators

Fang Li, M.D,.PH.D. (1)  ·  Jianwu Dai, Ph.D (1)